Technical Analysis for BDX - Becton, Dickinson and Company

Grade Last Price % Change Price Change
A 244.73 -2.25% -5.63
BDX closed up 1.71 percent on Tuesday, December 7, 2021, on 1.24 times normal volume. The stock crossed above its 200 day moving average, improving its long-term outlook by crossing above that critical trendline.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Up Up Up
Historical BDX trend table...

Date Alert Name Type % Chg
Crossed Above 200 DMA Bullish -2.26%
MACD Bullish Centerline Cross Bullish -2.26%
MACD Bullish Signal Line Cross Bullish -2.26%
Multiple of Ten Bullish Other -2.26%
Up 3 Days in a Row Strength -2.26%
Up 4 Days in a Row Strength -2.26%
Up 5 Days in a Row Strength -2.26%
Upper Bollinger Band Touch Strength -2.26%
200 DMA Resistance Bearish -0.58%
Shooting Star Candlestick Bearish -0.58%
Older End-of-Day Signals for BDX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
20 DMA Support 38 minutes ago
20 DMA Resistance about 1 hour ago
10 DMA Support about 1 hour ago
50 DMA Support about 1 hour ago
1.5x Volume Pace about 1 hour ago
View Earlier Intraday Alerts

Get a Trading Sidekick!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Becton, Dickinson and Company Description

Becton, Dickinson and Company, a medical technology company, develops, manufactures, and sells medical devices, instrument systems, and reagents worldwide. The company's BD Medical segment produces medical devices that are used in various healthcare settings. This segment's products include needles, syringes, and intravenous catheters for medication delivery; prefilled IV flush syringes; syringes and pen needles used in treatment of diabetes; prefillable drug delivery systems; anesthesia needles and trays; sharps disposal containers; and closed-system transfer devices. Its BD Diagnostics segment provides products for the collection and transport of diagnostics specimens; and instrument systems and reagents to detect various infectious diseases, healthcare-associated infections, and cancers. This segment's products comprise integrated systems for specimen collection; safety-engineered blood collection products and systems; automated blood culturing systems; molecular testing systems; microorganism identification and drug susceptibility systems; liquid-based cytology systems; rapid diagnostic assays; microbiology laboratory automation; and plated media. The company's BD Biosciences segment offers research and clinical tools that facilitate the study of cells and their components. This segment's products include fluorescence-activated cell sorters and analyzers; monoclonal antibodies and kits for performing cell analysis; reagent systems for life science research; cell imaging systems; laboratory products for tissue culture and fluid handling; diagnostic assays; and cell culture media supplements for biopharmaceutical manufacturing. The company markets its products through independent distribution channels and sales representatives to healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry, and the general public. Becton, Dickinson and Company was founded in 1897 and is headquartered in Franklin Lakes, New Jersey.


Classification

Sector: Healthcare
Industry: Medical Instruments & Supplies
Keywords: Medicine S&P 500 Biotechnology Biology Pharmaceutical Industry Infectious Diseases Diabetes Antibodies Cancers Medical Technology Monoclonal Antibodies Catheter Medical Devices Drug Delivery Medical Tests Catheters Anesthesia Microbiology Syringe Laboratory Products Healthcare Institutions Treatment Of Diabetes Drug Delivery Systems Flow Cytometry Drug Delivery System Sharps Cell Culture Clinical Tools Becton Becton Dickinson Culture Media Healthcare Setting Pharmaceutical Manufacturing Reagent Systems Transfer Devices

Is BDX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 267.37
52 Week Low 235.17
Average Volume 1,404,861
200-Day Moving Average 246.64
50-Day Moving Average 244.07
20-Day Moving Average 245.03
10-Day Moving Average 244.11
Average True Range 4.69
ADX 14.31
+DI 26.82
-DI 17.54
Chandelier Exit (Long, 3 ATRs) 238.61
Chandelier Exit (Short, 3 ATRs) 250.06
Upper Bollinger Bands 251.02
Lower Bollinger Band 239.03
Percent B (%b) 0.94
BandWidth 4.89
MACD Line 0.07
MACD Signal Line -0.30
MACD Histogram 0.3771
Fundamentals Value
Market Cap 72.57 Billion
Num Shares 290 Million
EPS 2.71
Price-to-Earnings (P/E) Ratio 92.38
Price-to-Sales 3.94
Price-to-Book 2.91
PEG Ratio 2.65
Dividend 3.32
Dividend Yield 1.33%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 258.76
Resistance 3 (R3) 258.60 255.63 257.36
Resistance 2 (R2) 255.63 253.49 255.72 256.89
Resistance 1 (R1) 253.00 252.17 254.32 253.16 256.43
Pivot Point 250.03 250.03 250.69 250.12 250.03
Support 1 (S1) 247.40 247.89 248.72 247.56 244.29
Support 2 (S2) 244.43 246.57 244.52 243.83
Support 3 (S3) 241.80 244.43 243.36
Support 4 (S4) 241.96